marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2022-Q3
added 12-23-2023
Aerie Pharmaceuticals Financial Statements 2011-2024 | AERI
Annual Financial Statements Aerie Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
325 M | 620 M | 1.1 B | 1.5 B | 2.11 B | 1.24 B | 426 M | 673 M | 88.8 M | - | - |
Shares |
46.3 M | 45.9 M | 45.4 M | 41.7 M | 35.3 M | 29.1 M | 25.8 M | 24.1 M | 4.96 M | - | - |
Historical Prices |
7.02 | 13.5 | 24.2 | 36.1 | 59.8 | 37.9 | 24.4 | 29.2 | 18 | - | - |
Net Income |
-74.8 M | -183 M | -200 M | -233 M | -145 M | -99.1 M | -74.4 M | -48.1 M | -31.1 M | -15 M | -13 M |
Revenue |
194 M | 83.1 M | 69.9 M | 24.2 M | - | - | - | - | - | - | - |
Cost of Revenue |
26.8 M | 25.3 M | 4.83 M | 641 K | - | - | - | - | - | - | - |
Gross Profit |
- | 57.8 M | 65.1 M | 23.5 M | - | - | - | - | - | - | - |
Operating Income |
-46.4 M | -156 M | -187 M | -210 M | -146 M | -96.9 M | -75.1 M | -50 M | -22.2 M | -14.3 M | -14.2 M |
Interest Expense |
-27.9 M | -22.2 M | -12.2 M | -22.8 M | -1.17 M | 2.54 M | 2.49 M | 628 K | 3.8 M | 75 K | 109 K |
EBITDA |
-40 M | -149 M | -182 M | -207 M | -144 M | -95.9 M | -74.8 M | -49.9 M | -22.1 M | -14.2 M | -13.3 M |
Operating Expenses |
- | 213 M | 253 M | 233 M | 146 M | 96.9 M | 75.1 M | 50 M | 22.2 M | - | - |
General and Administrative Expenses |
138 M | 137 M | 138 M | 121 M | 73.6 M | 44.5 M | 30.6 M | 20.1 M | 10.3 M | 5.02 M | 3.52 M |
All numbers in USD currency
Quarterly Income Statement Aerie Pharmaceuticals
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
- | 47.8 M | 47.6 M | 47.5 M | 48.4 M | 46.3 M | 46.2 M | 46.1 M | 46.8 M | 45.9 M | 45.9 M | 45.8 M | 46.5 M | 45.4 M | 45.4 M | 45.3 M | 45.5 M | 43.7 M | 39.2 M | 38.6 M | 36.9 M | 36.2 M | 34.8 M | 33.8 M | 33.5 M | 29.4 M | 26.8 M | 26.7 M | 26.5 M | 26.1 M | 25.8 M | 24.6 M | 24 M | 24.3 M | 23.9 M | 23.7 M | 23.3 M | 1.01 M | 982 K | 965 K | 965 K | 965 K | - | - | - | - | - | - |
Net Income |
- | -26.8 M | -19.4 M | -35.9 M | - | -39.7 M | -38.7 M | -42 M | -46.1 M | -39.6 M | -48.2 M | -49.1 M | -55.1 M | -49.4 M | -47.2 M | -48 M | -51.5 M | -85.4 M | -55 M | -40.7 M | -58.5 M | -32.4 M | -28.4 M | -25.8 M | -29.3 M | -23.8 M | -23.2 M | -22.7 M | -20.4 M | -18 M | -18.8 M | -17.2 M | -16.5 M | -13.1 M | -11.8 M | -6.67 M | -16.5 M | -10.7 M | -6.33 M | -3.79 M | -10.3 M | -3.59 M | -6.46 M | -3.93 M | - | - | - | - |
Revenue |
- | - | - | 29.8 M | - | 29.3 M | 27.2 M | 23 M | 24.7 M | 20.1 M | 18 M | 20.3 M | 24.7 M | 18.5 M | 15.8 M | 10.9 M | 14.5 M | 7.3 M | 2.42 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | 6.78 M | - | 7.9 M | 6.18 M | 6.7 M | - | 5.38 M | 7.33 M | 6.09 M | - | 2.06 M | 705 K | 381 K | - | 205 K | 59 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | -26.7 M | -18.1 M | -33.6 M | - | -32.4 M | -31.5 M | -34.2 M | - | -33.6 M | -42.6 M | -43.9 M | - | -43.3 M | -46.1 M | -48.2 M | - | -61.3 M | -55.7 M | -40.8 M | - | -32.2 M | -27.8 M | -25.4 M | -28.8 M | -23.3 M | -22.7 M | -22.1 M | -20 M | -17.4 M | -18.1 M | -19.6 M | -16 M | -13.2 M | -11.8 M | -8.98 M | -16 M | -13.2 M | -11.8 M | -8.98 M | -6.75 M | -5.69 M | -5.11 M | -4.62 M | - | - | - | - |
Interest Expense |
- | -59 K | -1.19 M | -1.56 M | - | -7.26 M | -7.17 M | -7.71 M | - | -6.04 M | -5.63 M | -5.22 M | - | -6.08 M | -1.09 M | 111 K | - | -24 M | 663 K | 96 K | - | 597 K | 604 K | 597 K | - | 600 K | 622 K | 688 K | - | 629 K | 622 K | 617 K | - | - | - | - | - | 1.48 M | 1.09 M | 293 K | - | 15 K | - | - | - | - | - | - |
EBITDA |
- | -26.7 M | -18.1 M | -32 M | - | -32.4 M | -31.5 M | -32.7 M | - | -28.9 M | -39.4 M | -42.3 M | - | -39.7 M | -44 M | -47.6 M | - | -59.6 M | -54.6 M | -40.3 M | - | -31.3 M | -27.2 M | -25.1 M | -28.8 M | -22.6 M | -22.2 M | -21.9 M | -20 M | -17.3 M | -18.1 M | -19.6 M | -16 M | -13.1 M | -11.8 M | -8.97 M | -16 M | -13.1 M | -11.8 M | -8.97 M | -6.75 M | -5.58 M | -5.11 M | -4.62 M | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 40.8 M | 60.3 M | 32.2 M | 27.8 M | 25.4 M | 28.8 M | 23.3 M | 22.7 M | 22.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
- | - | - | 31.5 M | - | 34.7 M | 34.5 M | 32.6 M | - | 32 M | 33.2 M | 36.9 M | - | 32.2 M | 34.5 M | 36.3 M | - | 32.7 M | 33.1 M | 22.9 M | - | 19.8 M | 17.2 M | 14.5 M | - | 10.6 M | 9.39 M | 9.8 M | - | 7.46 M | 7.5 M | 8.02 M | - | 4.94 M | 5.17 M | 3.61 M | - | 3.29 M | 1.94 M | 1.47 M | - | 1.42 M | - | - | - | - | - | - |
All numbers in USD currency